Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND4 pseudogene 35 (MTND4P35) is a nuclear pseudogene related by sequence to the mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 (MT-ND4) gene. The functional MT-ND4 gene encodes a core protein of mitochondrial complex I (NADH dehydrogenase), essential for oxidative phosphorylation and implicated in several mitochondrial diseases. However, MT-ND4 pseudogenes like MTND4P35 are characterized by sequence disruptions such as frameshifts and premature stop codons, which prevent expression of a functional protein. As such, MTND4P35 does not produce a protein subunit, does not participate in cellular respiratory function, and is not known or classified as a receptor, enzyme, transporter, or recognized therapeutic target. There are no established disease links, molecular functions, approved drugs, or safety concerns associated with this pseudogene[6][7]. Additional Clarification: Extensive research and clinical reference data describe the *functional* MT-ND4 gene and its protein product and disease associations, but no reputable scientific or clinical resources describe MTND4P35 (the pseudogene) as a therapeutic or biological target[6][7]. Nuclear pseudogenes for mitochondrial genes have been identified in human genomes through genomic analysis, but these do not encode active proteins and are not considered drug targets or biomarker candidates. If structured information is required about the *functional* gene (MT-ND4), consult results specifically referring to MT-ND4, not pseudogenes such as MTND4P35[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND4 pseudogene 35 (MTND4P35).